18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States
360 949 1041
https://www.absci.com
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 155
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Sean McClain | Founder, CEO, President & Director | 1,01M | S.O. | 1990 |
Dr. Zachariah Jonasson Ph.D. | Chief Business Officer & CFO | 331,64k | S.O. | 1973 |
Dr. Andreas Busch Ph.D. | Chief Innovation Officer & Member of Scientific Advisory Board | 1,13M | S.O. | 1963 |
Mr. Todd Bedrick CPA | Senior VP & Chief Accounting Officer | S.O. | S.O. | S.O. |
Mr. Alexander Khan CPA | VP of Finance & Head of Investor Relations | S.O. | S.O. | S.O. |
Ms. Karin Wierinck | Chief People Officer | S.O. | S.O. | S.O. |
Melissa Patterson Ph.D. | Chief of Staff | S.O. | S.O. | S.O. |
Jens Plassmeier Ph.D. | Senior VP of Biologics Discovery Technology | S.O. | S.O. | S.O. |
Mr. Wen Sha | Chief of Staff | S.O. | S.O. | S.O. |
Dr. Christine Lemke D.V.M., M.B.A., Ph.D. | Senior Vice President of Portfolio & Growth Strategy | S.O. | S.O. | S.O. |
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.
L’ISS Governance QualityScore de Absci Corporation en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..